Molecular Tumor Board Review and Improved Overall Survival in Non–Small-Cell Lung Cancer

With the introduction of precision medicine, treatment options for non–small-cell lung cancer have improved dramatically; however, underutilization, especially in disadvantaged patients, like those living in rural Appalachian regions, is associated with poorer survival. Molecular tumor boards (MTBs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Bin, Chen, Quan, Allison, Derek, El Khouli, Riham, Peh, Keng Hee, Mobley, James, Anderson, Abigail, Durbin, Eric B., Goodin, Donald, Villano, John L., Miller, Rachel W., Arnold, Susanne M., Kolesar, Jill M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492377/
https://www.ncbi.nlm.nih.gov/pubmed/34622117
http://dx.doi.org/10.1200/PO.21.00210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492377/
https://www.ncbi.nlm.nih.gov/pubmed/34622117
http://dx.doi.org/10.1200/PO.21.00210

Ejemplares similares